Artificial intelligence reads CT scans to forecast pancreatic cancer prognosis
NCT ID NCT06760234
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study used artificial intelligence to analyze CT scans and tissue samples from 247 pancreatic cancer patients. The goal was to create a model that predicts how the cancer will behave and how well patients will respond to chemotherapy. The model showed promising accuracy, but more testing is needed before it can be widely used.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this AI model could help doctors better predict how pancreatic cancer will progress and which patients will benefit from chemotherapy.
What could go wrong
This is a completed study that developed a model, but it needs further validation in larger, diverse groups before it can be used in routine care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
the Second Affiliated Hospital Zhejiang University School of Medicine
Hangzhou, Zhejiang, 310009, China